Related Experiment Video
Updated: Dec 27, 2025

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
Co-Incidence of Type II Topoisomerase Mutations and Efflux Expression in High Fluoroquinolone Resistant Enterococcus
Sarvenaz Esfahani1, Roya Ahmadrajabi1, Hamidreza Mollaei1
1Department of Microbiology and Virology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Introduction:
Enterococcus faecalis is one of the most common pathogens in urinary tract infections (UTIs). Fluoroquinolones have been frequently used to treat E. faecalis UTIs, and the emergence of fluoroquinolone-resistant E. faecalis strains has recently been reported in several countries. This study aimed to elucidate the mechanisms involved in fluoroquinolone resistance in clinical E. faecalis isolates by analyzing mutations in quinolone- resistance-determining regions (QRDRs) of gyrA and parC and investigating the role of some efflux pumps.
Methods:
In total, 70 clinical E. faecalis isolates collected from UTIs were identified by phenotypic and genotypic methods. Antimicrobial susceptibility testing was performed and multidrug-resistant (including ciprofloxacin resistant) isolates were studied for minimum inhibitory concentrations to ciprofloxacin, levofloxacin, and ofloxacin. In the following, mutations in QRDRs of gyrA and parC and expression of EfrA, EfrB, and EmeA efflux pumps were investigated in 20 high-level ciprofloxacin resistant and two ciprofloxacin susceptible isolates.
Results:
High-level resistance to ciprofloxacin was detected in 97.5% of isolates. Sequencing of QRDRs revealed that 65% and 75% of isolates carried mutations in gyrA and parC, respectively. The presence of efflux genes was detected in all studied isolates, but expression of efrA, emeA, and efrB was demonstrated in 50%, 40%, and 30% of resistant isolates, respectively. Neither QRDR mutation nor the expression of efflux genes showed any significant association with MIC.
Conclusion:
Co-incidence of mutation and efflux gene expression in more than half of isolates (13/20) suggests that both mechanisms may play a role in fluoroquinolone resistance. The other unknown mechanisms including different efflux pumps and probably other QRDRs mutations may contribute to fluoroquinolone resistance in E. faecalis.
Insights
Fluoroquinolone resistance in Enterococcus faecalis urinary tract infections is common, often involving mutations in gyrA and parC. Both mutations and efflux pump gene expression likely contribute to this resistance, though other mechanisms may also be involved.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Enterococcus faecalis is a primary cause of urinary tract infections (UTIs).
- Fluoroquinolones are common UTI treatments, but resistance is increasing.
- Emergence of fluoroquinolone-resistant E. faecalis strains necessitates understanding resistance mechanisms.
Purpose of the Study:
- To investigate fluoroquinolone resistance mechanisms in clinical E. faecalis UTI isolates.
- To analyze mutations in quinolone-resistance-determining regions (QRDRs) of gyrA and parC.
- To assess the role of EfrA, EfrB, and EmeA efflux pumps in resistance.
Main Methods:
- Phenotypic and genotypic identification of 70 E. faecalis UTI isolates.
- Antimicrobial susceptibility testing and minimum inhibitory concentration (MIC) determination.
- Sequencing of gyrA and parC QRDRs and investigation of efflux pump gene expression (EfrA, EfrB, EmeA) in resistant isolates.
Main Results:
- High-level ciprofloxacin resistance (97.5%) was prevalent in E. faecalis isolates.
- Mutations in gyrA (65%) and parC (75%) were common.
- Efflux genes were present in all isolates, with varying expression levels in resistant strains (EfrA 50%, EmeA 40%, EfrB 30%).
- No significant association was found between QRDR mutations, efflux gene expression, and MIC values.
Conclusions:
- Co-occurrence of QRDR mutations and efflux gene expression in over half of resistant isolates suggests combined roles in fluoroquinolone resistance.
- Additional unknown mechanisms, including other efflux pumps or QRDR mutations, may contribute to fluoroquinolone resistance in E. faecalis.
Related Concept Videos
Urinary Tract Infection II: Pathophysiology
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Development of Antibiotic Resistance

